Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pharma May See Brighter Enforcement Environment After US Justice Department Policy Changes

Dec 18 2018

• By Sue Sutter

LONDON, UK - MARCH 26TH 2018: The symbol of the United States Department of Justice portrayed with the US flag, on 26th March 2018. - Image

Related Content

From White House To White Oak: US FDA Taps Stacy Cline Amin For Chief Counsel Post

Sep 07 2018

Government Pharma Investigations Target Pricing, Opioids, Trade Practices

Sep 05 2018

Does Former Warner Chilcott Exec’s Arrest Portend More Prosecutions?

Nov 02 2015

US FDA May Clarify When Execs Can Be Criminally Prosecuted Under Park Doctrine

Dec 06 2017

Actelion Is Third Company To Settle Charity Co-Pay Kickback Claims With DOJ

Dec 07 2018

Gilead False Claims Case: Government Opposes Supreme Court Review But Thinks Suit Should Be Tossed

Dec 03 2018

US FDA’s Lowell Schiller Steps In As Acting Chief Counsel When Rebecca Wood Departs In July

Jun 29 2018

Related Companies

Gilead Sciences, Inc.

Additional Topics

United States Enforcement Compliance Legal Issues Regulation BioPharmaceutical

More from Compliance

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.